NCI | Technology Transfer

Glypican 2 As A Cancer Marker And Therapeutic Target

Read more about Glypican 2 As A Cancer Marker And Therapeutic Target

Australia
2016354440
Filed on 2016-11-08

Mutated Pseudomonas Exotoxins with Reduced Antigenicity

Read more about Mutated Pseudomonas Exotoxins with Reduced Antigenicity

Poland
15191388.6
Filed on 2015-10-26

Mutated Pseudomonas Exotoxins with Reduced Antigenicity

Read more about Mutated Pseudomonas Exotoxins with Reduced Antigenicity

Italy
15191388.6
Filed on 2015-10-26

Mutated Pseudomonas Exotoxins with Reduced Antigenicity

Read more about Mutated Pseudomonas Exotoxins with Reduced Antigenicity

Ireland
15191388.6
Filed on 2015-10-26

Mutated Pseudomonas Exotoxins with Reduced Antigenicity

Read more about Mutated Pseudomonas Exotoxins with Reduced Antigenicity

United Kingdom
15191388.6
Filed on 2015-10-26

Mutated Pseudomonas Exotoxins with Reduced Antigenicity

Read more about Mutated Pseudomonas Exotoxins with Reduced Antigenicity

France
15191388.6
Filed on 2015-10-26

Mutated Pseudomonas Exotoxins with Reduced Antigenicity

Read more about Mutated Pseudomonas Exotoxins with Reduced Antigenicity

Spain
15191388.6
Filed on 2015-10-26

Mutated Pseudomonas Exotoxins with Reduced Antigenicity

Read more about Mutated Pseudomonas Exotoxins with Reduced Antigenicity

Germany
15191388.6
Filed on 2015-10-26

Mutated Pseudomonas Exotoxins with Reduced Antigenicity

Read more about Mutated Pseudomonas Exotoxins with Reduced Antigenicity

Switzerland
15191388.6
Filed on 2015-10-26

Methods Of Preparing T Cells For T Cell Therapy

Read more about Methods Of Preparing T Cells For T Cell Therapy

New Zealand
741653
Filed on 2018-04-16

Subscribe to NCI